A collaboration between a drug plan and clinical pharmacists led to nearly 50% of members successfully switching to a preferred dipeptidyl-peptidase-4 inhibitor.

Signing up to the service couldn't be easier. It costs £15 for a rolling one-month subscription, or you can get it for £14 if ...

For overweight or obese individuals without diabetes, but with pre-existing cardiovascular disease, semaglutide (Ozempic, Wegovy) is not ...

Antiobesity drugs are amazing people by how fast they melt off pounds. But it's no surprise to Richard DiMarchi.

As employers grapple with including GLP-1s in their benefits packages, they face a complex decision that boils down to two main factors: human resources and finance. On one side, there's the potential ...

Recent market research reveals that glucagon-like peptide-1 (GLP-1) injections are set to dominate the obesity treatment ...

First-in-Human Study Provides Evidence that Sana’s Hypoimmune (HIP) Technology Enables Transplanted Islet Cells to Avoid Immune Rejection and ...

This may start to bring down the cost of brand-name competitors—here's who might get access, and one major difference from ...

Intuitively, it would seem that GLP-1 use for obesity would reduce overall medical costs despite the increase in drug ...

Insurers said one major driver of higher premiums is the growing popularity of a relatively new class of injectable drugs to ...

More than 5,600 Amazon shoppers have given Bliss Bright Idea Vitamin C + Tri-Peptide Facial Serum a five-star rating, with many highlighting the pleasant scent and texture of the serum as well as the ...